Onconetix Inc. (ONCO)
NASDAQ: ONCOHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ONCO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.43M
- P/E (TTM)
- 0.00
- EPS (TTM)
- $310.39
- Dividend yield
- None
- 52-week range
- 0.58 – 207.00
- Day range
- 0.60 – 0.8553
- Volume / Avg
- 46.50M / 2.96M
- Beta
- —
- Shares outstanding
- 5.24M
52-week range
ONCO stock today
On Oct 8, ONCO ended the session at $0.6543, adding $0.0571 (9.56%), versus the S&P 500's 0.47% decline. Volume was 15.7x the average at 46.50M shares, a sign of unusually heavy trading. Shares are 99.7% below their 52-week high of $207.00 and 12.8% above the 52-week low of $0.58, near the bottom of the past year's range.
Onconetix trades at 0.0x its trailing twelve-month earnings per share of $310.39.
Summary generated from market data by MetaCap's automated system. Methodology
About Onconetix
Company profileOnconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. David Allan White C.A., C.P.A., ICD.D
- Headquarters
- Cincinnati, OH
- Employees
- 2
- IPO year
- 2022
- Website
- onconetix.com
Onconetix peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HCWBHCW Biologics Inc. | 1.53 | -1.92% | $3.42M | vs ONCO |
| SXTP60 Degrees Pharmaceuticals Inc. | 0.9725 | -11.59% | $3.42M | vs ONCO |
| SLXNSilexion Therapeutics Corp | 0.2349 | -7.37% | $3.40M | vs ONCO |
| XRTXXORTX Therapeutics Inc. | 1.85 | +6.02% | $3.36M | vs ONCO |
| CMNDClearmind Medicine Inc. | 6.60 | 0.00% | $3.35M | vs ONCO |
| CVKDCadrenal Therapeutics Inc. | 0.9296 | -4.39% | $3.32M | vs ONCO |
| APVOAptevo Therapeutics Inc. | 1.80 | -2.17% | $3.26M | vs ONCO |
| KAPAKairos Pharma Ltd. | 0.9595 | +10.29% | $3.25M | vs ONCO |
Indexes, lists and sector
Appears in lists
Onconetix stock FAQ
What is Onconetix's stock price today?
ONCO last traded at $0.6543 as of Oct 8, 4:00 PM EDT, up 9.56% on the day. Prices are delayed at least 15 minutes.
What is ONCO's P/E ratio?
ONCO trades at a trailing P/E ratio of 0.00.
Who is Onconetix's CEO?
Mr. David Allan White C.A., C.P.A., ICD.D is the chief executive officer of Onconetix Inc., which has about 2 employees.
What is the ONCO 52-week high?
The 52-week high for ONCO is $207.00 and the 52-week low is $0.58. The stock is currently 99.7% below its high.